IL6 and cancer: ApcMin/+ mice, mice that bear a germline mutation in the adenomatous polyposis coli gene (APC), have elevated serum levels of IL-6, and they develop muscle tissue loss and the cancer cachexia phenotype, whereas, ApcMin/+/IL-6−/− mice do not.